UBS Investment Bank has announced coupon payments for five ETRACS Exchange Traded Notes (ETNs) traded on the NYSE Arca and expected payments for three ETNs traded on NASDAQ. The announcement was made in New York on May 6, 2025.
The ETRACS ETNs are linked to various indices including the Solactive US High Dividend Low Volatility Index Series B, Solactive US Small Cap High Dividend Index Series B, Solactive Preferred Stock ETF Index, S-Network Composite Closed-End Fund Index, Market Vectors Global Mortgage REITs Index, Credit Suisse Nasdaq Gold FLOWSTM 103 Index, Credit Suisse Nasdaq Silver FLOWSTM 106 Index, and Credit Suisse Nasdaq WTI Crude Oil FLOWSTM 106 Index.
A cautionary statement regarding forward-looking statements was included in the release. It emphasized that these statements are subject to risks and uncertainties which may cause actual results to differ materially from expectations. "Forward-looking statements...are based on management’s current expectations and assumptions," UBS stated. The company is not obligated to update these statements.
ETRACS ETNs are senior unsecured notes issued by UBS AG and can be bought or sold through brokers or financial advisors. They carry investment risks including potential loss of principal and depend on the creditworthiness of UBS AG. Investors are advised to review risk factors detailed in the prospectus supplements.
UBS AG has filed a registration statement with the Securities and Exchange Commission (SEC) for securities offerings related to this communication. Prospective investors should read relevant documents available via EDGAR on the SEC website or request them directly from UBS.
UBS is a global wealth manager headquartered in Zurich, Switzerland, managing $6.1 trillion as of Q4 2024. In the U.S., its securities activities are conducted by UBS Securities LLC and UBS Financial Services Inc., both registered broker/dealers.
This material was issued by UBS AG or its affiliates solely for informational purposes. Redistribution without permission is prohibited.
For media inquiries, contact Alison Keunen at +1-212-713-2296 or alison.keunen@ubs.com.